Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (291-300 of 894) with videos related to

Pageof 90
Sort By:
Expert Opinion on Investigational Drugs|September 24, 2008
Investigational drugs for diabetic nephropathyMonica Cortinovis, Dario Cattaneo, Norberto Perico, et al.
Lancet (London, England)|April 23, 2019
Orphan drugs - Authors' replyLucio Luzzatto, Enrico Costa, Arrigo Schieppati, et al.
Journal of Nephrology|September 24, 2002
Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiencyRoberto Pisoni, Rita Faraone, Piero Ruggenent, et al.
Kidney International. Supplement|August 20, 2005
Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?Norberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Kidney International. Supplement|March 9, 2005
Pathophysiology of disease progression in proteinuric nephropathiesNorberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Trends in Molecular Medicine|February 21, 2025
Is there a place for engineered immune cell therapies in autoimmune diseases?Luca Perico, Federica Casiraghi, Ariela Benigni, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2009
Hepatitis C infection and chronic renal diseasesNorberto Perico, Dario Cattaneo, Boris Bikbov, et al.
Kidney International. Supplement|December 13, 2005
The role of renin-angiotensin-aldosterone system in the progression of chronic kidney diseaseGiuseppe Remuzzi, Norberto Perico, Manuel Macia, et al.
Giornale Italiano Di Cardiologia (2006)|March 15, 2006
[Considerations on clinical drug research in Italy]Luigi Tavazzi, Silvio Garattini, Pier Mannuccio Mannucci, et al.
Kidney International|April 5, 2003
Predicting end-stage renal disease: Bayesian perspective of information transfer in the clinical decision-making process at the individual levelBorislav D Dimitrov, Annalisa Perna, Piero Ruggenenti, et al.
Pageof 90

Showing results (291-300 of 894) with videos related to

Sort By:
Pageof 90
Expert Opinion on Investigational Drugs|September 24, 2008
Investigational drugs for diabetic nephropathyMonica Cortinovis, Dario Cattaneo, Norberto Perico, et al.
Lancet (London, England)|April 23, 2019
Orphan drugs - Authors' replyLucio Luzzatto, Enrico Costa, Arrigo Schieppati, et al.
Journal of Nephrology|September 24, 2002
Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiencyRoberto Pisoni, Rita Faraone, Piero Ruggenent, et al.
Kidney International. Supplement|August 20, 2005
Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?Norberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Kidney International. Supplement|March 9, 2005
Pathophysiology of disease progression in proteinuric nephropathiesNorberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Trends in Molecular Medicine|February 21, 2025
Is there a place for engineered immune cell therapies in autoimmune diseases?Luca Perico, Federica Casiraghi, Ariela Benigni, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2009
Hepatitis C infection and chronic renal diseasesNorberto Perico, Dario Cattaneo, Boris Bikbov, et al.
Kidney International. Supplement|December 13, 2005
The role of renin-angiotensin-aldosterone system in the progression of chronic kidney diseaseGiuseppe Remuzzi, Norberto Perico, Manuel Macia, et al.
Giornale Italiano Di Cardiologia (2006)|March 15, 2006
[Considerations on clinical drug research in Italy]Luigi Tavazzi, Silvio Garattini, Pier Mannuccio Mannucci, et al.
Kidney International|April 5, 2003
Predicting end-stage renal disease: Bayesian perspective of information transfer in the clinical decision-making process at the individual levelBorislav D Dimitrov, Annalisa Perna, Piero Ruggenenti, et al.
Pageof 90